All SARS-CoV-2 articles
-
NewsTissue-resident immune cells defend human lungs from viral, bacterial, and fungal infections
A study shows that human lung tissue serves as a “reservoir” for a large number of tissue-resident memory T cells.. These cells stand ready to combat a surprising range of viruses, bacteria, and even deadly fungal pathogens.
-
NewsStudy shows targeted school closures can improve pandemic response
New research shows that school closures during a pandemic outbreak are most effective when they are carefully targeted. The study demonstrates that the right strategy depends on which age groups are driving transmission at different stages of an outbreak.
-
NewsRemdesivir for COVID-19 linked to better outcomes for adult kidney transplant recipients
Adults with kidney transplants who were treated for COVID-19 with the antiviral remdesivir within a week of diagnosis were less likely than kidney transplant recipients who did not receive the antiviral to experience cardiovascular or kidney problems up to a year later.
-
NewsCOVID-19 vaccines remain effective despite helminth-induced immune modulation
In a preclinical study, researchers have found that mRNA- and protein-based SARS-CoV-2 vaccines effectively protected Schistosoma-infected mice against the virus, despite the mice’s distinct immune response profiles.
-
News COVID-19 booster strategies provide lasting immunity
Smaller doses of COVID-19 booster vaccines can provide long-lasting immunity, helping to reduce costs and improve access to vaccination, according to research. The findings could also inform vaccine dosing and options during future pandemics.
-
NewsHow did the COVID-19 pandemic shift seasonal surges of other respiratory diseases?
A new analysis explores what underlies shifts in the timing of seasonal surges of respiratory diseases, as well as shifts in surges of heart-related deaths, that occurred after the COVID-19 pandemic began.
-
NewsEye problems after COVID-19 can now be explained
Mild COVID-19 can cause severe and long-lasting eye problems, according to a study from Linköping University, Sweden. The study also explains why it has been difficult for sufferers to get help: the abnormal eye behaviour cannot be detected by standard methods. The researchers have developed a diagnostic model to detect ...
-
NewsCommonly used drugs show small benefit for long Covid fatigue
Over-the-counter antihistamines and a prescription anti-inflammatory drug both have a small benefit in reducing long Covid fatigue among people receiving care from specialist long Covid clinics, according to new findings from a large clinical trial.
-
NewsA bacterium capable of predicting the course of a disease
A research team made use of the bacterium’s natural capabilities without altering it genetically. Using plasma samples from patients with COVID-19, they were able to distinguish patients likely to develop a mild form of the disease from those at risk of progressing to a severe form.
-
NewsNo entry: Blocking viruses from entering cells
The Volkswagen Foundation funds a project by UdS, HIPS, and HZI to create an innovative platform for developing viral entry inhibitors—specifically targeting respiratory viruses and other viruses that pose a pandemic risk.
-
NewsCOVID’s lingering shadow faded after Omicron — but not for everyone
A long-term study of long Covid has found that whilst lingering symptoms became far less common after the Omicron variant arrived, some people have continued to experience health problems years after infection.
-
NewsCommon COVID-19 drugs may pose hidden risks to marine life, study finds
A new study suggests that several drugs widely used during the COVID-19 pandemic can be toxic to marine organisms, even at relatively low concentrations. Five pharmaceuticals were tested on nauplii of the brine shrimp Artemia salina.
-
ArticleCOVID-19 vaccine boosters may help protect against future animal coronaviruses
COVID-19 vaccine boosters not only protect against SARS‑CoV‑2 but may also help protect against some future coronaviruses that risk spreading from animals to humans, researchers have shown.
-
NewsStudy: Three-in-one vaccine shows promise against ‘tripledemic’
A single-shot vaccine in development could protect against flu, COVID-19 and RSV simultaneously. In a study, researchers found that their three-in-one vaccine triggered protective immunity against all three respiratory diseases in mice, ferrets and cotton rats.
-
NewsBillions of doses later: Global review confirms mRNA vaccines are safe, effective and full of promise
A comprehensive review brings together global evidence to strengthen public trust and counter misinformation as mRNA vaccines expand to prevent and treat more diseases.
-
NewsNatural compound may help boost vaccine responses
A team of researchers has found that the naturally occurring compound spermidine can help boost vaccine response in older adults by reducing molecular markers of immune system ageing.
-
NewsHidden protein linked to severe COVID-19 and lung disease risk
A genetic difference carried by nearly one in three people may increase the risk of severe COVID-19 and lung fibrosis by disrupting the function of a previously unknown protein, according to a new study.
-
OpinionWhy cruise ships remain vulnerable to viral outbreaks - and how new technologies could help
A dream holiday can quickly become a public health challenge when thousands of people share the same dining rooms, elevators and living spaces. Recent viral outbreaks on cruise ships have shown just how vulnerable these floating cities remain to infectious diseases.
-
NewsMetformin given during acute COVID-19 infection reduced risk of clinician-diagnosed long Covid by 50%
New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established safety record, reduced the risk of clinician-diagnosed long COVID when started during acute COVID-19 infection.
-
NewsAntibody clues could improve long Covid care and prognosis
Researchers have found that SARS-CoV-2 antibody patterns may help assess infection history, symptom severity, and cognitive complications in long Covid.